Omeros Corporation (OMER) names investor Joseph Schocken to board and Audit Committee
Rhea-AI Filing Summary
Omeros Corporation expanded its Board of Directors to nine members and appointed Joseph Schocken as a director effective August 12, 2026. His initial term runs until the Company’s 2027 annual meeting of shareholders or earlier resignation or removal.
Schocken, 79, is a private investor and founder and president of Tranceka Capital, LLC, with a long history in investment banking and public-company leadership. He was also a driving participant in national economic policy discussions and the JOBS Act and currently serves as chairman of Taqtile, Inc.
Under Omeros’ non-employee director compensation policy, Schocken received a stock option to purchase 30,000 shares of common stock on his appointment date and will be covered by the Company’s standard director indemnification agreement. He joins the Board’s Audit Committee, and the Company states he has no disclosable material interests in related-party transactions.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Board size: 9 directors
Stock option grant: 30,000 shares
Director term end: 2027 annual meeting of shareholders
+1 more
4 metrics
Board size
9 directors
Number of directors after August 12, 2026 appointment
Stock option grant
30,000 shares
Option to purchase common stock granted to Joseph Schocken on appointment
Director term end
2027 annual meeting of shareholders
Scheduled expiration of Joseph Schocken’s initial board term
Age of new director
79
Age of Joseph Schocken at time of appointment
Key Terms
non-employee director compensation policy, indemnification agreement, Audit Committee, Item 404(a) of Regulation S-K
4 terms
non-employee director compensation policy financial
"Pursuant to our non-employee director compensation policy, Mr. Schocken was granted a stock option"
indemnification agreement regulatory
"Mr. Schocken will be indemnified by the Company pursuant to the terms of our standard form of director indemnification agreement"
An indemnification agreement is a contract in which one party promises to cover losses, costs, or legal claims that another party might face, acting like a tailored safety net or private insurance policy. For investors, it matters because such agreements shift potential financial risk away from a company or its officers and onto the indemnifier, which can affect a company’s future liabilities, cash flow and how risky the investment appears during deal-making or litigation.
Audit Committee financial
"The Board of Directors also appointed Mr. Schocken to the Audit Committee of the Board of Directors"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Item 404(a) of Regulation S-K regulatory
"no direct or indirect material interest in any existing or currently proposed transaction that would require disclosure under Item 404(a) of Regulation S-K"
FAQ
What did Omeros Corporation (OMER) announce regarding its board on August 12, 2026?
Omeros Corporation’s board increased its size to nine directors and appointed Joseph Schocken as a new director effective August 12, 2026. His initial term extends until the 2027 annual meeting of shareholders, unless he resigns or is removed earlier.
Who is Joseph Schocken, the new director of Omeros Corporation (OMER)?
Joseph Schocken, 79, is a private investor and founder of Tranceka Capital, LLC. He previously founded Broadmark Capital LLC, helped create Broadmark Realty Capital, Inc., and currently serves as chairman of Taqtile, Inc., a digital work assistance platform.
What board committees will Joseph Schocken serve on at Omeros Corporation (OMER)?
Joseph Schocken has been appointed to the Audit Committee of Omeros Corporation’s Board of Directors. This committee oversees financial reporting and related internal controls as described in the company’s governance structure and supported by independent director participation.
What equity compensation is Joseph Schocken receiving as an Omeros (OMER) director?
Under Omeros’ non-employee director compensation policy, Joseph Schocken received a stock option to purchase 30,000 shares of common stock on his appointment date. This equity grant aligns with the company’s standard approach for compensating its outside directors.
How long will Joseph Schocken serve on the board of Omeros Corporation (OMER)?
Joseph Schocken’s initial term as a director will expire at Omeros’ 2027 annual meeting of shareholders. His service could end earlier if he resigns or is removed, consistent with the company’s standard governance provisions and director terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
